APRE Aprea Therapeutics, Inc.
Healthcare$0.95+2.15%ClosedMarket Cap: $6.2M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Rating Distribution
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-31 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-31 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-10 | Wedbush | maintain | Outperform | Outperform |
| 2026-01-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-18 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.65 | $2.3M | 3 |
| Sun Dec 31 | $-0.73 | $4.0M | 4 |
| Mon Dec 31 | $-0.48 | $12.2M | 2 |
| Tue Dec 31 | $0.26 | $66.6M | 2 |